348 related articles for article (PubMed ID: 26692349)
1. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
[TBL] [Abstract][Full Text] [Related]
2. The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor.
Mohyeldin MM; Akl MR; Ebrahim HY; Dragoi AM; Dykes S; Cardelli JA; El Sayed KA
Oncotarget; 2016 May; 7(22):32247-73. PubMed ID: 27086914
[TBL] [Abstract][Full Text] [Related]
3. Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-Met.
Ebrahim HY; Elsayed HE; Mohyeldin MM; Akl MR; Bhattacharjee J; Egbert S; El Sayed KA
Phytother Res; 2016 Apr; 30(4):557-66. PubMed ID: 26744260
[TBL] [Abstract][Full Text] [Related]
4. Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models.
Akl MR; Ayoub NM; Mohyeldin MM; Busnena BA; Foudah AI; Liu YY; Sayed KA
PLoS One; 2014; 9(5):e97622. PubMed ID: 24849787
[TBL] [Abstract][Full Text] [Related]
5. Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancer.
Busnena BA; Foudah AI; Melancon T; El Sayed KA
Bioorg Med Chem; 2013 Apr; 21(7):2117-27. PubMed ID: 23403296
[TBL] [Abstract][Full Text] [Related]
6. (-)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers.
Elnagar AY; Sylvester PW; El Sayed KA
Planta Med; 2011 Jul; 77(10):1013-9. PubMed ID: 21328179
[TBL] [Abstract][Full Text] [Related]
7. Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies.
Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Kamal AM; Haggag EG; El Sayed KA
Nutr Cancer; 2017; 69(8):1256-1271. PubMed ID: 29083228
[TBL] [Abstract][Full Text] [Related]
8. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.
Ebrahim HY; Mohyeldin MM; Hailat MM; El Sayed KA
Bioorg Med Chem; 2016 Nov; 24(22):5748-5761. PubMed ID: 27681240
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the Histone Deacetylase HdaA in Endophytic Fungus
Ding Z; Zhou H; Wang X; Huang H; Wang H; Zhang R; Wang Z; Han J
Molecules; 2020 Aug; 25(16):. PubMed ID: 32796640
[TBL] [Abstract][Full Text] [Related]
10. 13
Souid S; Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Karoui H; El Sayed KA; Essafi-Benkhadir K
Mol Carcinog; 2018 Nov; 57(11):1507-1524. PubMed ID: 29978911
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory action of naphtho[1,2-b]furan-4,5-dione on hepatocyte growth factor-induced migration and invasion of MDA-MB-231 cells: mechanisms of action.
Tsai PC; Chu CL; Tseng CH; Chen YL; Chang LS; Lin SR
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):716-26. PubMed ID: 24909202
[TBL] [Abstract][Full Text] [Related]
12. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
13. A natural short pathway synthesizes roquefortine C but not meleagrin in three different Penicillium roqueforti strains.
Kosalková K; Domínguez-Santos R; Coton M; Coton E; García-Estrada C; Liras P; Martín JF
Appl Microbiol Biotechnol; 2015 Sep; 99(18):7601-12. PubMed ID: 25998659
[TBL] [Abstract][Full Text] [Related]
14. Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling.
Parr C; Ali AY
J Transl Med; 2018 Oct; 16(1):281. PubMed ID: 30314527
[TBL] [Abstract][Full Text] [Related]
15. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
Elsayed HE; Ebrahim HY; Haggag EG; Kamal AM; El Sayed KA
Bioorg Med Chem; 2017 Dec; 25(24):6297-6312. PubMed ID: 29066046
[TBL] [Abstract][Full Text] [Related]
16. The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.
Chen L; Li C; Zhu Y
Oncotarget; 2015 Oct; 6(30):30088-101. PubMed ID: 26254225
[TBL] [Abstract][Full Text] [Related]
17. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
18. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
Foudah AI; Sallam AA; Akl MR; El Sayed KA
Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
[TBL] [Abstract][Full Text] [Related]
19. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
20. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
